FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,245 | -52.9% | 125,587 | +5.7% | 0.00% | – |
Q2 2023 | $565,469 | -19.5% | 118,796 | -3.6% | 0.00% | – |
Q1 2023 | $702,588 | +46.7% | 123,261 | +159.6% | 0.00% | – |
Q4 2022 | $479,063 | -58.2% | 47,479 | -7.2% | 0.00% | – |
Q3 2022 | $1,146,000 | -2.8% | 51,166 | +7.6% | 0.00% | – |
Q2 2022 | $1,179,000 | -97.0% | 47,550 | -95.3% | 0.00% | -100.0% |
Q1 2022 | $39,356,000 | -23.8% | 1,015,117 | +14.9% | 0.01% | -16.7% |
Q4 2021 | $51,680,000 | +623.9% | 883,279 | +633.3% | 0.01% | +500.0% |
Q3 2021 | $7,139,000 | -90.7% | 120,447 | -86.4% | 0.00% | -89.5% |
Q2 2021 | $76,734,000 | +37.4% | 884,134 | +30.6% | 0.02% | +26.7% |
Q1 2021 | $55,831,000 | +44.9% | 677,136 | +59.8% | 0.02% | +36.4% |
Q4 2020 | $38,541,000 | +199.9% | 423,856 | +31.8% | 0.01% | +175.0% |
Q3 2020 | $12,853,000 | +1412.1% | 321,547 | +1197.9% | 0.00% | – |
Q2 2020 | $850,000 | -74.0% | 24,774 | -83.2% | 0.00% | -100.0% |
Q1 2020 | $3,275,000 | +222.0% | 147,462 | +194.3% | 0.00% | – |
Q2 2019 | $1,017,000 | +8.9% | 50,107 | -5.8% | 0.00% | – |
Q1 2019 | $934,000 | +2.8% | 53,179 | -25.0% | 0.00% | – |
Q4 2018 | $909,000 | -90.5% | 70,862 | -87.9% | 0.00% | -100.0% |
Q3 2018 | $9,559,000 | +362.5% | 586,778 | +222.0% | 0.00% | +200.0% |
Q2 2018 | $2,067,000 | +2985.1% | 182,236 | +778.8% | 0.00% | – |
Q2 2017 | $67,000 | +17.5% | 20,736 | +66.4% | 0.00% | – |
Q1 2017 | $57,000 | – | 12,465 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |